Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX)
CUSIP: 00972G207
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Ordinary Shares, $0.000000005 par value
- Shares outstanding
- 94,284,567,045
- Total 13F shares
- 121,755
- Share change
- -1,287
- Total reported value
- $379,836
- Price per share
- $3.12
- Number of holders
- 7
- Value change
- -$22,758
- Number of buys
- 3
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 00972G207?
CUSIP 00972G207 identifies AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00972G207:
Top shareholders of AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
178,091
|
$703,459 | — | 30 Sep 2023 | |
| Omnia Family Wealth, LLC |
13F
|
Company |
0%
|
59,117
|
$233,512 | — | 30 Sep 2023 | |
| Cerity Partners LLC |
13F
|
Company |
0%
|
23,643
|
$93,390 | — | 30 Sep 2023 | |
| NEA Management Company, LLC |
13F
|
Company |
0%
|
22,608
|
$89,303 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0%
|
17,469
|
$69,000 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
150
|
$592 | — | 30 Sep 2023 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
50
|
$198 | — | 30 Sep 2023 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
5
|
$20 | — | 30 Sep 2023 |
Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) as of Q4 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.